tiprankstipranks
Trending News
More News >
Aclaris Therapeutics (ACRS)
NASDAQ:ACRS
US Market
Advertisement

Aclaris Therapeutics (ACRS) Technical Analysis

Compare
774 Followers

Technical Sentiment

Overall Consensus
Sell
7Bullish
3Neutral
12Bearish
Technical Analysis Consensus
Neutral
4Bullish
3Neutral
3Bearish
Moving Average Consensus
Strong Sell
3Bullish
0Neutral
9Bearish
Aclaris Therapeutics’s (ACRS) Moving Averages Convergence Divergence (MACD) indicator is 0.03, suggesting Aclaris Therapeutics is a Buy.
Aclaris Therapeutics’s (ACRS) 20-Day exponential moving average is 1.58, while Aclaris Therapeutics’s (ACRS) share price is $1.53, making it a Sell.
Aclaris Therapeutics’s (ACRS) 50-Day exponential moving average is 1.53, while Aclaris Therapeutics’s (ACRS) share price is $1.53, making it a Buy.

Aclaris Therapeutics (ACRS) Pivot Points

Aug 01, 2025, 08:47 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.04
1.27
1.40
1.63
1.76
1.99
2.12
Fibonacci
1.27
1.41
1.49
1.63
1.77
1.85
1.99
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Aclaris Therapeutics (ACRS) Moving Averages

Aug 01, 2025, 08:47 PM
Period
Simple
Exponential
MA5
1.60Sell
1.57Sell
MA10
1.62Sell
1.59Sell
MA20
1.58Sell
1.58Sell
MA50
1.50Buy
1.53Buy
MA100
1.44Buy
1.57Sell
MA200
1.98Sell
1.75Sell
Aclaris Therapeutics’s (ACRS) 10-Day exponential moving average is 1.59, while Aclaris Therapeutics’s (ACRS) share price is $1.53, making it a Sell.
Aclaris Therapeutics’s (ACRS) 100-Day exponential moving average is 1.57, while Aclaris Therapeutics’s (ACRS) share price is $1.53, making it a Sell.
Aclaris Therapeutics’s (ACRS) stock price is $1.53 and Aclaris Therapeutics’s (ACRS) 50-day simple moving average is 1.50, creating a Buy signal.
Aclaris Therapeutics’s (ACRS) stock price is $1.53 and Aclaris Therapeutics’s (ACRS) 100-day simple moving average is 1.44, creating a Buy signal.
Aclaris Therapeutics’s (ACRS) stock price is $1.53 and Aclaris Therapeutics’s (ACRS) 200-day simple moving average is 1.98, creating a Sell signal.

Aclaris Therapeutics (ACRS) Technical Indicators

Aug 01, 2025, 08:47 PM
Name
Value
Implied Action
RSI (14)
47.05
Neutral
STOCH (9,6)
10.02
Buy
STOCHRSI (14)
13.57
Buy
MACD (12,26)
0.03
Buy
ADX (14)
34.16
Neutral
Williams %R
-82.46
Buy
CCI (14)
-77.27
Neutral
ATR (14)
0.12
-
Ultimate Oscillator
29.79
Sell
ROC
-2.55
Sell
Aclaris Therapeutics’s (ACRS) Relative Strength Index (RSI) is 47.05, creating a Neutral signal.
Aclaris Therapeutics’s (ACRS) Trend Strength Indicator (ADX) is 34.16, creating a Neutral signal.
Aclaris Therapeutics’s (ACRS) Commodity Channel Index (CCI) is -77.27, creating a Neutral signal.
Aclaris Therapeutics’s (ACRS) Price Rate of Change (ROC) is -2.55, creating a Sell signal.

FAQ

Is ACRS a Buy, Hold, or Sell?
Based on ACRS’s technical indicators, ACRS is a Sell.
    What is ACRS’s RSI (14)?
    ACRS’s RSI (14) is 47.05, which suggests ACRS is a Neutral.
      What is ACRS’s MACD?
      ACRS’s MACD is 0.03, which suggests ACRS is a Buy.
        What is ACRS’s 5-day moving average?
        ACRS’s 5-day moving average is 1.60, which suggests ACRS is a Sell.
          What is ACRS’s 20-day moving average?
          ACRS 20-day moving average is 1.58, which suggests ACRS is a Sell.
            What is ACRS’s 50-day moving average?
            ACRS’s 50-day moving average is 1.50, which suggests ACRS is a Buy.
              What is ACRS’s 200-day moving average?
              ACRS’s 200-day moving average is 1.98, which suggests ACRS is a Sell.
                What is ACRS’s Williams % R (14)?
                ACRS’s Williams % R (14) is -82.46, which suggests ACRS is a Buy.
                  What is ACRS’s CCI (14)?
                  ACRS’s CCI (14) is -77.27, which suggests ACRS is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis